Where Vision Becomes Reality

Read More

Stason currently holds a portfolio of approved ANDAs

Read More

Developing Products. Building Partnerships

Read More

Quality cannot be tested into products; it has to be built in by Design

Read More


Stason entered the US generic market in 1994, and currently holds a portfolio of approved ANDAs.


Stasons cutting-edge cGMP manufacturing capabilities include facilities from pilot plant and clinical


In 2008, Stason launched the Brand Division when we acquired exclusive development


We collaborate with our global partners to commercialize products across the Pacific

Development Services

Stason offers contract services to drug development companies that need a qualified facility and support staff with capabilities to formulate, optimize and test, clinical trial materials and commercial products.


Celebrating 20 Years

  • CPhI Worldwide.

"US-based manufacturing, global distribution network.”
  • client3

    US Sales & Marketing